Ticagrelor benefits in TWILIGHT hold up in diabetes
23 Apr 2020
byRoshini Claire Anthony
Dropping aspirin after 3 months of dual therapy with ticagrelor reduced bleeding in patients with diabetes who have undergone PCI* vs taking both agents for 1 year, the TWILIGHT-DM** study has shown, consistent with benefits seen in TWILIGHT for other high-risk patients.
